GUANGZHOU, China, April 22, 2026 (GLOBE NEWSWIRE) — Pony AI Inc. (“Pony.ai” or the “Company”) (NASDAQ: PONY; HKEX: 2026), a global leader in achieving large-scale mass production and commercialization of autonomous driving technology, today announced that it will hold an annual general meeting of the Company’s shareholders (the “AGM”) at 10:00 a.m. (Beijing time) on June 8, 2026 at 1/F, Building 8, Phase II, Datang Industrial Park, Huangge Town, Nansha District, Guangzhou, Guangdong Province, PRC, for the purposes of considering and, if thought fit, passing each of the Proposed Resolutions as defined and set forth in the notice of the AGM (the “AGM Notice”). A circular of the Company dated April 22, 2026 in relation to the AGM, the AGM Notice and the form of proxy for the AGM are available on the Company’s website at https://ir.pony.ai....

GUANGZHOU, China, April 22, 2026 (GLOBE NEWSWIRE) — Pony AI Inc. (“Pony.ai” or the “Company”) (NASDAQ: PONY; HKEX: 2026), a global leader in achieving large-scale mass production and commercialization of autonomous driving technology, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission (the “SEC”). The annual report can be accessed on the Company’s investor relations website at https://ir.pony.ai. The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to the Company’s Investor Relations Department at ir@pony.ai. The Company today also announced that it published its inaugural...

AON leaders to speak on panels focused on advocacy, innovation and access in independent community oncology FORT MYERS, Fla., April 22, 2026 (GLOBE NEWSWIRE) — American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, today announced it will participate in 11 speaking sessions at the 2026 Community Oncology Alliance (COA) Annual Conference. The event, themed Innovation in Practice, will take place April 28-29 in Orlando, Florida.“At AON, we are committed to advancing community oncology through innovation that supports local practices and improves patient outcomes,” said Stephen “Fred” Divers, MD, AON’s chief medical officer, medical oncologist at Genesis Cancer and Blood Institute, and officer-at-large on COA’s Executive Committee. “The conference provides an important platform to share...

The Company will continue trading on the Nasdaq Capital Market under the ticker symbol “SKIN” LONG BEACH, Calif., April 22, 2026 (GLOBE NEWSWIRE) — The Beauty Health Company (NASDAQ: SKIN) today announced a corporate rebrand to SkinHealth Systems Inc., marking its evolution into a clinically driven, science-backed medical aesthetics company. The Company will operate under the new name effective immediately while continuing to trade on the Nasdaq Capital Market under the same ticker symbol, “SKIN.” The Company’s new name will be reflected on the Nasdaq Capital Market effective April 23, 2026. The transition to SkinHealth Systems reflects the Company’s ambition to build an unparalleled offering of skin health solutions that combines devices and consumables backed by scientific and clinical validation. It also signals a shift toward...

LOS ANGELES, April 22, 2026 (GLOBE NEWSWIRE) — LiveOne (Nasdaq: LVO), a leading music, entertainment, and technology platform, today announced a series of strategic financial and operational milestones that significantly enhance its balance sheet and reinforce long-term growth initiatives. “This is an important step toward strengthening our balance sheet and eliminating going concern opinions,” said Robert Ellin, Chairman and CEO of LiveOne. “By reducing near-term obligations and executing on our stock conversion strategy, we are enhancing financial stability and positioning the Company for long-term growth.” About LiveOne Headquartered in Los Angeles, CA, LiveOne (Nasdaq: LVO) is an award-winning, creator-first, music, entertainment, and technology platform focused on delivering premium experiences and content worldwide through...

ST. LOUIS, April 22, 2026 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first patients in the US have been successfully treated using MAGiC™. MAGiC, Stereotaxis’ proprietary robotically-navigated magnetic interventional cardiac ablation catheter, recently received Food & Drug Administration PMA approval. It is the first ablation catheter specifically approved to treat arrhythmia in patients with complex congenital heart disease. Dr. Nathan McConkey, Cardiac Electrophysiologist at Oregon Health & Science University, performed the first MAGiC procedure in the United States on a patient with complex congenital heart disease who was experiencing extremely frequent episodes of atrial flutter, requiring...

MONTREAL, April 22, 2026 (GLOBE NEWSWIRE) — Volatus Aerospace Inc. (TSX: FLT) (OTCQB: TAKOF) (FSE: ABB.F) (“Volatus” or the “Company”), a Canadian-headquartered global aerospace and defence company, today announced the appointment of Major General (Ret’d) Peter M. “Pete” Fesler to its Advisory Board, completing the formation of a multinational group of senior defence leaders aligned with Canada’s evolving Defence Industrial Strategy. Major General Fesler brings more than 27 years of service in the United States Air Force, including command of the 1st Fighter Wing and senior leadership roles at NORAD, where he served as Deputy Director of Operations responsible for aerospace warning and control across North America. A command pilot with over 2,200 flight hours in F-15 and F-22 aircraft and more than 50 combat missions, he is widely...